Reactive arthritis following COVID-19: cause for concern

Low-quality evidence suggests that COVID-19 may trigger reactive arthritis one to four weeks after the infection. Post COVID-19 reactive arthritis resolves within a few days, and no additional treatment is required. Established diagnostic or classification criteria for reactive arthritis are missing...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliorini, Filippo, Karlsson, Jon, Maffulli, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942056/
https://www.ncbi.nlm.nih.gov/pubmed/36809513
http://dx.doi.org/10.1007/s00167-023-07332-z
_version_ 1784891410588106752
author Migliorini, Filippo
Karlsson, Jon
Maffulli, Nicola
author_facet Migliorini, Filippo
Karlsson, Jon
Maffulli, Nicola
author_sort Migliorini, Filippo
collection PubMed
description Low-quality evidence suggests that COVID-19 may trigger reactive arthritis one to four weeks after the infection. Post COVID-19 reactive arthritis resolves within a few days, and no additional treatment is required. Established diagnostic or classification criteria for reactive arthritis are missing, and a deeper understanding of the immune mechanism related to COVID-19 prompt us to further investigate the immunopathogenic mechanisms capable of promoting or contrasting the development of specific rheumatic diseases. Caution should be exerted when managing post-infectious COVID-19 patient with arthralgia.
format Online
Article
Text
id pubmed-9942056
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99420562023-02-21 Reactive arthritis following COVID-19: cause for concern Migliorini, Filippo Karlsson, Jon Maffulli, Nicola Knee Surg Sports Traumatol Arthrosc Editorial Low-quality evidence suggests that COVID-19 may trigger reactive arthritis one to four weeks after the infection. Post COVID-19 reactive arthritis resolves within a few days, and no additional treatment is required. Established diagnostic or classification criteria for reactive arthritis are missing, and a deeper understanding of the immune mechanism related to COVID-19 prompt us to further investigate the immunopathogenic mechanisms capable of promoting or contrasting the development of specific rheumatic diseases. Caution should be exerted when managing post-infectious COVID-19 patient with arthralgia. Springer Berlin Heidelberg 2023-02-21 2023 /pmc/articles/PMC9942056/ /pubmed/36809513 http://dx.doi.org/10.1007/s00167-023-07332-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Editorial
Migliorini, Filippo
Karlsson, Jon
Maffulli, Nicola
Reactive arthritis following COVID-19: cause for concern
title Reactive arthritis following COVID-19: cause for concern
title_full Reactive arthritis following COVID-19: cause for concern
title_fullStr Reactive arthritis following COVID-19: cause for concern
title_full_unstemmed Reactive arthritis following COVID-19: cause for concern
title_short Reactive arthritis following COVID-19: cause for concern
title_sort reactive arthritis following covid-19: cause for concern
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942056/
https://www.ncbi.nlm.nih.gov/pubmed/36809513
http://dx.doi.org/10.1007/s00167-023-07332-z
work_keys_str_mv AT migliorinifilippo reactivearthritisfollowingcovid19causeforconcern
AT karlssonjon reactivearthritisfollowingcovid19causeforconcern
AT maffullinicola reactivearthritisfollowingcovid19causeforconcern

Ejemplares similares